Thank you for joining us as we had an astounding four days of exclusive, virtual sessions where private equity investors and industry experts delved into the insights and strategies shaping the future of healthcare investing.
For your convenience, please find the video recap and takeaways for day 1 below.
Access code: HPE2021
MISSION CRITICAL: ACTION PLANS FOR OPTIMIZING YOUR HEALTH INVESTMENTS
This insightful session brings you concrete strategies for your investments, including considerations for contingent purchase pricing, the benefits and the limits of R&W insurance for healthcare risks, tactics for combining two platforms in one sector, and regulatory and government enforcement trends and predictions.
Access code: HPE2021
2020 was a year of unprecedented disruption for healthcare services providers and dealmakers are still looking to get deals done even though it may be hard to agree upon current valuation. This panel addresses different types of disruption in financial performance and how to structure contingent purchase prices in a manner that is compliant and achieves business objectives.
Replay window | 0:00 – 30:05
Investors must conduct effective due diligence on even more potential areas of liability before executing on investments. While indemnification and R&W insurance can provide some protection, the competitive nature of auctions and indemnification-light trends may limit the value of R&W insurance for healthcare regulatory and underscores the importance of addressing certain critical healthcare regulatory items.
Replay window | 30:05 – 1:01:25
Scale in healthcare services is important to achieve efficiencies and prepare for risk-based contracting. Combining two healthcare services platforms presents a challenging task. This panel discusses how to address indemnification obligations from both sides, integrating physician and other professionals’ compensation, ancillary services optimization and other critical issues that investors need to know before they undertake the merger of two platforms.
Replay window | 1:01:25 – 1:31:50
During this session, the panelists update on regulatory developments concerning price transparency, surprise billing and the physician fee schedule. They also break down the Government’s healthcare fraud enforcement priorities—including provider relief fund (PRF) and telehealth fraud—and offer practical perspectives on how portfolio companies can reduce enforcement risk.